Mitchell Katz News
-
Bill Ackman’s quest to expose Herbalife Ltd. started with a tip from a friend. The call came from a reporter turned stock researcher, who had penned a book about the hedge fund manager’s last big short and was now telling him that Herbalife smelled like a pyramid scheme.
-
Weight training alone or with aerobic exercise may lower diabetes risk in men, Harvard University research showed, while a German study found that physical activity keeps those with the disease alive longer.
-
AstraZeneca Plc’s Nexium, Pfizer Inc.’s Protonix and Takeda Pharmaceutical Co.’s Prevacid, ulcer drugs also prescribed for indigestion, were linked to a higher risk of bone fractures in older women and to a diarrhea-causing infection, two studies found.
-
Nancy Kissel, accused of murdering her banker husband, broke down in a Hong Kong court today after saying that she wasn’t able to help their daughter and said she tried to protect herself from abuse by spiking his drinks.
-
Express Scripts Inc.’s takeover of Medco Health Solutions Inc. is offering the biggest potential windfall in North America even as traders are more confident than ever the acquisition will clear U.S. regulatory hurdles.
-
Grifols SA , Europe’s largest maker of blood-plasma products, fell the most in four months in Madrid trading after The Deal reported that U.S. antitrust regulators will seek to block the company’s purchase of Talecris Biotherapeutics Holdings Corp.
-
Even as U.S. regulators take a tougher stance on takeovers, traders are convinced they can reap the biggest return in America by betting Express Scripts Inc. will win antitrust approval to buy Medco Health Solutions Inc.
-
Brand-name drugmakers are continuing an “anticompetitive” trend of paying generic-drug manufacturers to delay introducing their lower-cost products, according to a Federal Trade Commission report.
-
Intel Corp. and the U.S. Federal Trade Commission filed a motion to suspend trial proceedings while the two work on a potential settlement of the government’s antitrust case against the chipmaker.
-
Laboratory Corp. of America can complete the purchase of rival clinical-testing company Westcliff Medical Laboratories Inc., a U.S. judge ruled, rejecting a challenge by the U.S. Federal Trade Commission.
|
|
Most Popular on Bloomberg
|
| |